All Viruses articles
-
ArticleCOVID-19 vaccine boosters may help protect against future animal coronaviruses
COVID-19 vaccine boosters not only protect against SARS‑CoV‑2 but may also help protect against some future coronaviruses that risk spreading from animals to humans, researchers have shown.
-
NewsStudy: Three-in-one vaccine shows promise against ‘tripledemic’
A single-shot vaccine in development could protect against flu, COVID-19 and RSV simultaneously. In a study, researchers found that their three-in-one vaccine triggered protective immunity against all three respiratory diseases in mice, ferrets and cotton rats.
-
![Low-Res_[1] KRICT Research Team](https://d3rmrttq0bsnxi.cloudfront.net/Pictures/100x67/3/0/4/21304_lowres_1krictresearchteam_295027.jpg)
NewsKRICT discovers novel SRV2 envelope protein for efficient car immune cell production
Researchers identify a novel SRV2 envelope protein that serves as a key to unlock immune cells, enabling more efficient delivery of anticancer genes and improving the production and therapeutic performance of CAR immune cells.
-
NewsBreakthrough for aquaculture: Oral vaccine protects fish from fatal nervous necrosis virus
A novel oral vaccine, that can be mixed into fish feed, provides an effective, practical and cost-effective method to protect fish from the highly deadly nervous necrosis virus.
-
NewsViruses under stress: how viral shells change shape as they dry out
New research explores the structural dynamics and conformational changes of bacteriophage MS2 capsids under conditions of dehydration.
-
NewsDiabetes worsens long COVID complications
In a study involving 870 participants, people with diabetes took longer to recover from the virus and experienced more severe cardiac complications, as well as greater physical and cognitive difficulties.
-
NewsResearchers affirm long-held belief that viruses can trigger Parkinson’s disease
Researchers have developed a model that uses a nontoxic way to generate the symptoms of Parkinson’s: infection with a virus. It proves that a simple viral infection can trigger the exact brain damage and physical disabilities in animal models that are seen in people with Parkinson’s disease.
-
NewsSame day administration of COVID-19 and influenza vaccines not associated with increase in adverse events
A target trial emulation found that same day coadministration of the COVID-19 and influenza vaccines was not associated with a higher risk of serious or clinically meaningful adverse events compared with receiving only an influenza vaccine.
-
NewsMount Sinai scientists develop first fully human monoclonal antibody cocktail that protects against Nipah and Hendra viruses
New preclinical study demonstrates that a novel monoclonal antibody cocktail provides complete protection against lethal Nipah and Hendra virus infection.
-
NewsSea anemone flips a human antiviral strategy on its head
A new study has uncovered a previously unknown antiviral defense mechanism in sea anemones, revealing that animals may have evolved more than one way to fight viral infections.
-
NewsGlobal burden of viral skin diseases rises 36% since 1990: Children and elderly bear the brunt
Global analysis of viral skin diseases underscores the need for equitable policies: while high-income countries have made progress via vaccination and better healthcare, low-resource regions lag behind.
-
NewsHow YouTube shapes public understanding of avian influenza
A new study analyzing more than 11,000 YouTube videos and comments found that online narratives surrounding avian influenza evolved alongside major outbreak developments, including increasing reports of infections in mammals, sporadic human cases, and economic consequences.
-
NewsPersistent herpes zoster-associated pain: New review uncovers mechanisms and supports earlier intervention
For millions, herpes zoster pain does not end when the rash fades. Postherpetic neuralgia can last for years, devastating quality of life. A comprehensive review has mapped the full cascade of mechanisms driving this persistent pain, providing support for earlier, more aggressive treatment.
-
NewsLong-term hepatitis control efforts dramatically reduce HBV and HCV burden in Japan
Researchers have estimated that the number of HBV infections in Japan could decline gradually down to around 200,000 cases by 2050, down from an estimate of 923,000 to 940,000 cases in 2020. HCV is estimated to decline to less than 20,000 cases.
-
NewsMicrobes rewrite the rules of cancer immunotherapy by triggering immunogenic cell death
A new study reveals that microbiota and their metabolites can effectively reprogram immunogenic cell death (ICD), a unique form of cell death that activates the body‘s immune system against tumors, transforming immunologically “cold” therapy-resistant tumors into “hot” responsive ones.
-
NewsHidden protein linked to severe COVID-19 and lung disease risk
A genetic difference carried by nearly one in three people may increase the risk of severe COVID-19 and lung fibrosis by disrupting the function of a previously unknown protein, according to a new study.
-
NewsResearch team awarded NIH grant to study congenital CMV transmission during pregnancy
A research team has received a new 5-year, $3.87 million R01 grant from the National Institutes of Health (NIH) to investigate how the immune system protects against congenital cytomegalovirus (CMV) infection.
-
NewsResearcher wins $5.6M NIH Avant Garde Award to prevent HIV, Hepatitis C and overdose
An innovative project will use AI-powered “digital twins” to help public health agencies better prevent HIV, hepatitis C and overdose among people who use drugs.
-
NewsWhy do viruses not kill the mosquitoes that transmit them?
A new study reveals the mechanism that allows viruses such as chikungunya or dengue to be harboured in mosquitoes without killing them, thus facilitating their transmission.
-
NewsProtective human antibodies target West Nile and related viruses
New research defines vulnerable sites on West Nile virus that could inform vaccine development, and highlight antibody candidates with prophylactic and therapeutic potential. They may also guide interventions for a wider group of encephalitic orthoflavivirus infections.